insights_auto
Why is 4AB up 3.28%?
Dive Deeperchevron_right
4AB:ETR
AbbVie Common Stock
€245.70
arrow_upward
+3.28%(+7.80) 1D
Oct 9, 5:35:35 PM GMT+2 · EUR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for 4AB...
Open
€242.00
High
€246.00
Low
€242.00
Mkt. cap
488.55B
Avg. vol.
666.00
Volume
106.00
52-wk high
€246.00
52-wk low
€162.85
No. of employees
57K
Open
€242.00
High
€246.00
Low
€242.00
Mkt. cap
488.55B
Avg. vol.
666.00
Volume
106.00
52-wk high
€246.00
52-wk low
€162.85
No. of employees
57K
News stories
From web sources and news partners
Simply Wall Street
·
4 hours ago
AbbVie (ABBV) Wins Two FDA Breakthrough Tags, Is The Stock Fully Priced?
Stock Titan
·
4 hours ago
93.3% of Crohn’s patients with fistulas who stayed on AbbVie’s RINVOQ reached clinical and steroid-free remission.
The Motley Fool
·
12 hours ago
AbbVie's Dividend Yield Is at Its Lowest Level Since 2018. Here's Why the Stock Is Still a Great Pick for Income Investors Anyway.
MarketWatch
·
2 days ago
AbbVie Inc. stock underperforms Friday when compared to competitors despite daily gains
Profile
AbbVie Inc., also known as AbbVie, is an American pharmaceutical company headquartered in North Chicago, Illinois. AbbVie produces drugs to treat a wide range of medical issues.
The company is ranked sixth on the list of largest biomedical companies by revenue. It is ranked 77th on the Fortune 500 and 108th on the Forbes Global 2000. The name "AbbVie" is derived from a combination of "Abbott", the name of its former parent company, with "vie", intended as a reference to a Latin root meaning 'life'. Wikipedia
About AbbVie Common Stock
CEORobert A. Michael
Employees57K
FoundedApr 10, 2012
HeadquartersNorth Chicago, Illinois, United States
SectorBiotechnology
Websiteabbvie.com